[18F]THK-5351
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]THK-5351, covering 2020-12-14 to 2020-12-14. Get the full timeline:
Most recent: Clinical Trial Update: [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease [Phase 2]